BK virus infections, also known as polyomavirus BK infection, are caused by the BK polyomavirus which can infect humans of all ages. BK virus usually remains dormant in the kidneys of healthy individuals. However, in immunocompromised individuals, especially those who have undergone organ transplantation, BK virus infection can lead to severe complications like nephropathy and hemorrhagic cystitis. The global BK virus infection market consists of diagnosis and treatment options for BK virus infections.
The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024 and is expected to reach USD 389 Mn by 2031, growing at a compound annual growth rate (CAGR) of 41.7% from 2024 to 2031.
Key players operating in the BK virus infection market are Clinigen Group plc, Teva Pharmaceutical Industries Ltd., Debiopharm Group, F. Hoffmann-La Roche Ltd., and Mylan N.V.
Rising prevalence of BK Virus (BKV) Infection Market post-transplantation and increasing awareness regarding its diagnosis and treatment present high-growth opportunities in the market. The market players are investing in R&D to develop newer treatment options and expand their geographic presence globally through collaborations. With growing organ transplant numbers globally, the market players have high opportunities for expansion in regions like Asia Pacific and Latin America. Collaborations with local players help them to provide best treatment solutions in emerging markets and spread awareness regarding BK virus infection management.
Market Drivers
Rising number of organ transplant procedures worldwide is a major market driver. As per the WHO, over 100,000 organ transplants are performed annually and the number is rising every year. This increases the risk of BK virus infections in immunocompromised transplant patients. Increasing awareness among physicians and patients regarding BK virus infection diagnosis, symptoms and management is another key driver. Continuous medical education and marketing initiatives by leading players help to spread awareness in a timely manner.
Market Restraints
High cost of treatment options like intravenous immunoglobulin and severe side effects of certain drugs like cidofovir limit their usage. This restrains the market growth especially in price-sensitive developing regions.
Segment Analysis
BK Virus Infection market can be segmented based on diagnostic type into molecular diagnosis and microscopy. The molecular diagnosis segment is dominating presently due to higher sensitivity and specificity of PCR and other nucleic acid-based techniques for detecting BK virus. The microscopy segment is declining due to limitations of traditional techniques like electron microscopy for diagnosis of BK virus infection. Based on disease type, the market can be classified into polyomavirus-associated nephropathy, hemorrhagic cystitis, and others. Polyomavirus-associated nephropathy segment holds the major share as BK virus remains the leading cause of rejection in kidney transplant recipients. The rising number of kidney transplant procedures globally is propelling the growth of this segment.
Global Analysis
North America dominates the global BK virus infection market owing to the rising incidence of polyomavirus-associated nephropathy, growing transplant procedures, well-established healthcare system, and presence of leading market players in this region. Asia Pacific is expected to witness the highest growth rate during the forecast period due to increasing healthcare spending, large population base, and growing awareness about BK virus infection and its diagnosis.
Get this Report in Japanese Language: BKウイルス（BKV）感染症市場
Get this Report in Korean Language: BK 바이러스(BKV) 감염 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Market OverviewThe Global Mononucleosis Diagnostic Market is expected to grow at a CAGR of 4.9% during the forecasting period (2020-2027).Mono, or mononucleosis, is an acute infectious disease caused by the Epstein-Barr virus (EBV).
Most cases of mono are mild and can be treated easily.
Adolescents and young adults (12 to 40 years old) are more likely to be affected.
Download free sample: https://www.datamintelligence.com/download-sample/mononucleosis-diagnostic-market Market DynamicsThe global mononucleosis diagnostic market is growing owing to several factors including rising incidence of infectious mononucleosis (IM), growing raising awareness and knowledge about mononucleosis, and increasing research & development activities for IM treatment.According to the Centers for Disease Control and Prevention, between 2002–2018, there were around 23,780 incident cases of infectious mononucleosis (IM), which results in an overall incidence rate of 104.2 cases per 100,000 person-years (p-yrs).
The incidence rate of IM diagnoses was reported higher among non-Hispanic white service members (123.4 per 100,000 p-yrs) compared to other race/ethnicity groups.
Among these, the monospot test segment accounted for the largest market share in 2018, owing to the several benefits associated with this test, such as accurate results, non-interference with other tests, cost-effectiveness, rapid detection of antibodies, among others.
Encephalitis is a rare, life-threatening disease which causes inflammation in the brain by either virus infection or immune system mistakenly destroys the healthy brain cell instead of the infected cell.
Rarely, it can also be caused by a bacterial or fungal infection.
It mostly occurs in children or older people or those who have a weekend immune system.
The symptoms of it vary with the severity of the disease.
Infants or children with encephalitis:
Bulging fontanel on the infant’s skull
